These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2715150)

  • 1. The detection of Clostridium perfringens epsilon antitoxin in rabbit serum by monoclonal antibody based competition ELISA.
    Sojka MG; White VJ; Thorns CJ; Roeder PL
    J Biol Stand; 1989 Apr; 17(2):117-24. PubMed ID: 2715150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
    ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An alternative to the toxin neutralization assay in mice for the potency testing of the Clostridium tetani, Clostridium septicum, Clostridium novyi type B and Clostridium perfringens type D epsilon components of multivalent sheep vaccines.
    Wood KR
    Biologicals; 1991 Oct; 19(4):281-6. PubMed ID: 1797039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme linked immunosorbent assay for potency testing of vaccines containing Clostridium perfringens type D epsilon-toxoid.
    Pfahler W; Bisesti E; Pereyra JB; Iribarren F
    Zentralbl Veterinarmed B; 1998 Apr; 45(3):133-9. PubMed ID: 9588107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and evaluation of a monoclonal antibody to Clostridium perfringens type D epsilon toxin.
    El-Enbaawy MI; Abdalla YA; Hussein AZ; Osman RM; Selim SA
    Egypt J Immunol; 2003; 10(1):77-81. PubMed ID: 15719625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of Clostridium perfringens vaccines using an indirect competitive ELISA for the epsilon toxin component - examination of the assay by a collaborative study.
    Rosskopf-Streicher U; Volkers P; Werner E
    Pharmeuropa Bio; 2004 Jan; 2003(2):91-6. PubMed ID: 14960265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and prevalidation of two different ELISA systems for the potency testing of Clostridium perfringens beta and epsilon-toxoid containing veterinary vaccines.
    Ebert E; Oppling V; Werner E; Cussler K
    FEMS Immunol Med Microbiol; 1999 Jul; 24(3):299-311. PubMed ID: 10397315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Clostridium perfringens type D epsilon antitoxin in serum of goats by competitive and indirect ELISA.
    Uzal FA; Nielsen K; Kelly WR
    Vet Microbiol; 1997 Sep; 57(2-3):223-31. PubMed ID: 9355257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified toxin-binding inhibition (ToBI) test for epsilon antitoxin determination in serum of immunized rabbits.
    Sobrinho EM; Cangussu AS; Brandi IV; Sari RS; Almeida AC; Colen F; Quintilio W; Santos HO
    Vet Immunol Immunopathol; 2010 Nov; 138(1-2):129-33. PubMed ID: 20709411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.
    Hauer PJ; Clough NE
    Dev Biol Stand; 1999; 101():85-94. PubMed ID: 10566780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro tests for the measurement of clostridial toxins, toxoids and antisera. II. Titration of Clostridium perfringens toxins and antitoxins in cell culture.
    Knight PA; Queminet J; Blanchard JH; Tilleray JH
    Biologicals; 1990 Oct; 18(4):263-70. PubMed ID: 2285500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative evaluation of the methods of determining perfringens A antitoxin].
    Shemanova GF; Trapezov EV; Musina EE; Vlasova EV; Panteleev EI
    Biull Eksp Biol Med; 1983 Nov; 96(11):82-4. PubMed ID: 6315110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxin.
    Borrmann E; Schulze F; Cussler K; Hänel I; Diller R
    Vet Microbiol; 2006 Apr; 114(1-2):41-50. PubMed ID: 16361070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of peptide based epsilon toxin vaccine by covalent anchoring to tetanus toxoid.
    Kaushik H; Dixit A; Garg LC
    Anaerobe; 2018 Oct; 53():50-55. PubMed ID: 29920342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of the toxin binding inhibition test for potency testing of Clostridium novyi type B alpha toxoid vaccines].
    Luick K; Gottschaldt J; Schulze F; Werner E; Erler W; Borrmann E
    Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):178-82. PubMed ID: 11998370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-phase radioimmunoassays for quantitative antibody determination of bacterial exotoxins. Measurement of Clostridium perfringens type D epsilon antitoxin.
    Bernáth S
    Dev Biol Stand; 1976; 32():77-83. PubMed ID: 187514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin.
    McClain MS; Cover TL
    Infect Immun; 2007 Apr; 75(4):1785-93. PubMed ID: 17261609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the in vitro neutralization test of Clostridium perfringens type A toxin.
    Shemanova GF; Vlasova EV; Postnikova TM
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(2):219-26. PubMed ID: 2900852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of in vitro methods for the potency testing of clostridial vaccines].
    Borrmann E; Schulze F; Diller R
    ALTEX; 2001; 18(1):34-6. PubMed ID: 11248848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.